Viewing Study NCT06541704


Ignite Creation Date: 2025-12-24 @ 9:14 PM
Ignite Modification Date: 2026-01-21 @ 11:46 AM
Study NCT ID: NCT06541704
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2024-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module